Considering that the mutation frequency of genes that serve as prediction signatures should not be too low, we investigated the mutation frequency of SERPINB3, DCHS2, and the above melanoma and NSCLC shared response-related genes in TCGA melanoma (SKCM) and lung cancer data. This evidence concerns the gene SERPINB3 and lung carcinoma.